Skip to main content
Top
Published in: AIDS and Behavior 8/2023

Open Access 21-01-2023 | Human Immunodeficiency Virus | Original Paper

Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men

Authors: Lorraine T. Dean, Zachary Predmore, Alexandra Skinner, Siena Napoleon, Philip A. Chan, Julia Raifman

Published in: AIDS and Behavior | Issue 8/2023

Login to get access

Abstract

Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention tool. Long-acting injectable PrEP (LAI-PrEP) offers another opportunity to reduce HIV. However, how at-risk individuals will consider LAI-PrEP over other modes of administration is unclear. We conducted a discrete choice experiment on preferences for PrEP among a sample of N = 688 gay, bisexual, and other men who have sex with men (GBMSM). We analyzed preferences for mode of administration, side-effects, monetary cost, and time cost using a conditional logit model and predicted preference for PrEP options. LAI-PrEP was preferred, despite mode of administration being the least important PrEP attribute. Side-effects were the most important attribute influencing preferences for PrEP (44% of decision); costs were second-most-important (35% of decision). PrEP with no side-effects was the most important preference, followed by monthly out-of-pocket costs of $0. Practitioners and policymakers looking to increase PrEP uptake should keep costs low, communicate clearly about PrEP side-effects, and allow the use of patient-preferred modes of PrEP administration, including LAI-PrEP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sullivan PS, Johnson AS, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397(10279):1095–106.CrossRefPubMed Sullivan PS, Johnson AS, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397(10279):1095–106.CrossRefPubMed
2.
go back to reference Fields SD, Tung E. Patient-focused selection of PrEP medication for individuals at risk of HIV: a narrative review. Infect Dis Therapy. 2021;10(1):165–86.CrossRef Fields SD, Tung E. Patient-focused selection of PrEP medication for individuals at risk of HIV: a narrative review. Infect Dis Therapy. 2021;10(1):165–86.CrossRef
4.
go back to reference Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United Stated and dependent areas, 2015. HIV Surveill Rep. 2016;27. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United Stated and dependent areas, 2015. HIV Surveill Rep. 2016;27.
5.
7.
go back to reference Ya-lin AH, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67(41):1147.CrossRef Ya-lin AH, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67(41):1147.CrossRef
8.
go back to reference Doblecki-Lewis S, Liu A, Feaster D, et al. Healthcare access and PrEP continuation in San Francisco and Miami following the US PrEP demo project. J Acquir Immune Defic Syndr. 2017;74(5):531.CrossRefPubMedPubMedCentral Doblecki-Lewis S, Liu A, Feaster D, et al. Healthcare access and PrEP continuation in San Francisco and Miami following the US PrEP demo project. J Acquir Immune Defic Syndr. 2017;74(5):531.CrossRefPubMedPubMedCentral
9.
go back to reference Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral
10.
go back to reference Crosby RA, Geter A, DiClemente RJ, Salazar LF. Acceptability of condoms, circumcision and PrEP among young black men who have sex with men: a descriptive study based on effectiveness and cost. Vaccines. 2014;2(1):129–37.CrossRefPubMedPubMedCentral Crosby RA, Geter A, DiClemente RJ, Salazar LF. Acceptability of condoms, circumcision and PrEP among young black men who have sex with men: a descriptive study based on effectiveness and cost. Vaccines. 2014;2(1):129–37.CrossRefPubMedPubMedCentral
11.
go back to reference Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2012;24(5):408–21.CrossRefPubMed Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2012;24(5):408–21.CrossRefPubMed
12.
go back to reference Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.CrossRefPubMedPubMedCentral Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.CrossRefPubMedPubMedCentral
14.
go back to reference Currie D. HIV prevention pill welcomed as new tool in AIDS battle: medication comes with high price tag. Nation’s Health. 2012;42(7):1–12. Currie D. HIV prevention pill welcomed as new tool in AIDS battle: medication comes with high price tag. Nation’s Health. 2012;42(7):1–12.
15.
go back to reference Kubicek K, Arauz-Cuadra C, Kipke MD. Attitudes and perceptions of biomedical HIV prevention methods: voices from young men who have sex with men. Arch Sex Behav. 2015;44(2):487–97.CrossRefPubMedPubMedCentral Kubicek K, Arauz-Cuadra C, Kipke MD. Attitudes and perceptions of biomedical HIV prevention methods: voices from young men who have sex with men. Arch Sex Behav. 2015;44(2):487–97.CrossRefPubMedPubMedCentral
18.
go back to reference Bridges JF, Selck FW, Gray GE, McIntyre JA, Martinson NA. Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Planning. 2011;26(4):298–306.CrossRefPubMed Bridges JF, Selck FW, Gray GE, McIntyre JA, Martinson NA. Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Planning. 2011;26(4):298–306.CrossRefPubMed
19.
go back to reference Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2002;37(6):1681–705.CrossRefPubMedPubMedCentral Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2002;37(6):1681–705.CrossRefPubMedPubMedCentral
20.
go back to reference Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.CrossRefPubMed Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.CrossRefPubMed
21.
go back to reference Sosnowy C, Predmore Z, Dean LT, et al. Paying for PrEP: A qualitative study of cost factors that impact pre-exposure prophylaxis uptake in the US. International Journal of STD & AIDS. 2022:09564624221132406. Sosnowy C, Predmore Z, Dean LT, et al. Paying for PrEP: A qualitative study of cost factors that impact pre-exposure prophylaxis uptake in the US. International Journal of STD & AIDS. 2022:09564624221132406.
22.
go back to reference To access the Appendix click on the Details tab in the article online. To access the Appendix click on the Details tab in the article online.
23.
go back to reference Dubov A, Ogunbajo A, Altice FL, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment. AIDS Care. 2019;31(5):545–53.CrossRefPubMed Dubov A, Ogunbajo A, Altice FL, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment. AIDS Care. 2019;31(5):545–53.CrossRefPubMed
24.
go back to reference Beckham S, Sanchez T, Zlotorzynska M, et al. Preferences for implementing long-acting injectable pre-exposure prophylaxis among cisgender men who have sex with men in the United States. J Int AIDS Soc. 2021;24(S4):29–31. Beckham S, Sanchez T, Zlotorzynska M, et al. Preferences for implementing long-acting injectable pre-exposure prophylaxis among cisgender men who have sex with men in the United States. J Int AIDS Soc. 2021;24(S4):29–31.
25.
go back to reference Gutierrez JI, Dubov A, Altice F, Vlahov D. Measuring PrEP preferences among US military men who have sex with men: results of an adaptive choice based conjoint analysis study. 2021. Gutierrez JI, Dubov A, Altice F, Vlahov D. Measuring PrEP preferences among US military men who have sex with men: results of an adaptive choice based conjoint analysis study. 2021.
26.
go back to reference Wray TB, Chan PA, Klausner JD, Ward LM, Ocean E. Gay, bisexual, and other men who have sex with men who are not on oral PrEP may be less interested in available injectable products than in oral PrEP: examining individual-level determinants of interest and barriers across products. AIDS Behav. 2022:1–12. Wray TB, Chan PA, Klausner JD, Ward LM, Ocean E. Gay, bisexual, and other men who have sex with men who are not on oral PrEP may be less interested in available injectable products than in oral PrEP: examining individual-level determinants of interest and barriers across products. AIDS Behav. 2022:1–12.
27.
go back to reference Dunville R, Harper C, Johns MM, et al. Awareness and willingness to use biomedical prevention strategies for HIV among sexual and gender minority youth: results from a national survey. J Adolesc Health. 2021;68(1):199–206.CrossRefPubMed Dunville R, Harper C, Johns MM, et al. Awareness and willingness to use biomedical prevention strategies for HIV among sexual and gender minority youth: results from a national survey. J Adolesc Health. 2021;68(1):199–206.CrossRefPubMed
28.
go back to reference Asiago-Reddy EA, McPeak J, Scarpa R, et al. Perceived access to PrEP as a critical step in engagement: a qualitative analysis and discrete choice experiment among young men who have sex with men. PLoS ONE. 2022;17(1): e0258530.CrossRefPubMedPubMedCentral Asiago-Reddy EA, McPeak J, Scarpa R, et al. Perceived access to PrEP as a critical step in engagement: a qualitative analysis and discrete choice experiment among young men who have sex with men. PLoS ONE. 2022;17(1): e0258530.CrossRefPubMedPubMedCentral
29.
go back to reference Keith K. New guidance On PrEP: support services must be covered without cost-sharing. health affairs blog. (2021). Accessed Jan 19 2022. Keith K. New guidance On PrEP: support services must be covered without cost-sharing. health affairs blog. (2021). Accessed Jan 19 2022.
30.
go back to reference Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed
31.
go back to reference Sullivan PS, Khosropour CM, Luisi N, et al. Bias in online recruitment and retention of racial and ethnic minority men who have sex with men. J Med Internet Res. 2011;13(2): e38.CrossRefPubMedPubMedCentral Sullivan PS, Khosropour CM, Luisi N, et al. Bias in online recruitment and retention of racial and ethnic minority men who have sex with men. J Med Internet Res. 2011;13(2): e38.CrossRefPubMedPubMedCentral
32.
go back to reference Ballard AM, Cardwell T, Young AM. Fraud detection protocol for web-based research among men who have sex with men: development and descriptive evaluation. JMIR Public Health Surveill. 2019;5(1): e12344.CrossRefPubMedPubMedCentral Ballard AM, Cardwell T, Young AM. Fraud detection protocol for web-based research among men who have sex with men: development and descriptive evaluation. JMIR Public Health Surveill. 2019;5(1): e12344.CrossRefPubMedPubMedCentral
33.
go back to reference Kates J, Dawson L, Horn TH, et al. Insurance coverage and financing landscape for HIV treatment and prevention in the USA. Lancet. 2021. Kates J, Dawson L, Horn TH, et al. Insurance coverage and financing landscape for HIV treatment and prevention in the USA. Lancet. 2021.
Metadata
Title
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
Authors
Lorraine T. Dean
Zachary Predmore
Alexandra Skinner
Siena Napoleon
Philip A. Chan
Julia Raifman
Publication date
21-01-2023
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2023
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-03986-5

Other articles of this Issue 8/2023

AIDS and Behavior 8/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare